Research and development growth to drive the growth of Global Cancer Biopsy Market, in the forecast period, 2022-2026.
According to TechSci Research report, “Global Cancer Biopsy Market By Product (Instruments, Kits and Consumables, Services), By Type of Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers), By Region, Competition Forecast & Opportunities, 2026”, the global cancer biopsy market is projected to show a robust growth in the forecast period from 2022 to 2026. The market growth can be attributed to the surge in the demand of early and efficient diagnostic of the various types of cancerous diseases that are prevailing, thus it is influencing the global cancer biopsy market, as biopsy is one of the diagnostic procedures for the cancerous cells. Moreover, technologically advanced medical devices are being developed that have been quite handful in the categorization of the cancer. Along with the diagnosis of the malignancy, these devices are also actively responsible in identifying the histology of the cancer as well as staging of the cancer thereby understanding the level of risk the patient is at. These advents are actively driving the growth of the global cancer biopsy market in the next five years until 2026.
Cancer is a chronic disorder that can be defined as the mass of unregulated cell growth that take place in a form of lump. They do not perform the set of functions they are expected to perform and rather multiply immaturely causing bumps and mass of cells that clutter at a single place. These clusters of cancerous cells may grow due to various reasons like, genetic abnormalities, environmental factors, virulent vectors or due to excessive exposure to various harmful radiations. Some chemical factors like poisonous chemical exposure may trigger the cancer causing genes and there by cause cancer. Cancer biopsy is a method of scoping and dissecting a piece of cancerous mass from the cancer affected area of the body and retrieving it for the further processes like diagnosis or research, etc. The recent trend has seen a shift in the method of biopsy, instead of tumor biopsy, experts are choosing liquid biopsy. Liquid biopsy is the sampling and analysis of non-solid biological tissue, preferably blood. This method is non-invasive and has provision of early diagnosis through screening and determines the risk of relapse of cancer after treatment. With the presence of biomarkers it can be beneficial in determining the best treatment plan as well as aids the research towards mechanism of resistance, disease progression, and identification of newer treatments.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on “Global Cancer Biopsy Market”
https://www.techsciresearch.com/report/cancer-biopsy-market/7399.html
The global cancer biopsy market is segmented on the basis of product, type of biopsy, application, end user, competitive landscape, and regional distribution. Based on type of biopsy the market is further bifurcated into tissue biopsies, liquid biopsies, and others. Liquid biopsies are anticipated to hold the largest market share owing to the increased demand for non-invasive method of diagnosis and research sampling procedures. Liquid biopsies require kits and consumable that are products required for the cancer biopsies which is co-dependently driving the market growth in the forecast period, until 2026. Tissue biopsies are sub-categorized into needle and surgical biopsies. Tissue biopsies are also expected to hold significant share of the market owing to the need of surgical graft of the tissues that are solid or if the cancer cells are not available in the blood. In certain cases, like breast cancer experts have to perform a surgical biopsy to reach the endothermal cells, or sometime needle biopsy is used in throat cancer. Increasing instances of these cancers is driving the growth of the market towards and is expected to continue in the forecast period as well.
Needle biopsies are the most popular choice among the experts owing to the efficiency, shorter wait time for the results (with fine needle aspiration, FNA type needle biopsies). Although various techniques demand surgical incisions like staging splenectomy for Hodgkin’s lymphoma patients. To perform these procedures with 100% efficiency the experts require right biopsy type for the right patients, appropriate sample processing, and accurate pathological examination, which is driving the market growth in the next five years.
Some of the major competitors in the market are Qiagen N.V., Illumina, Inc., ANGLE Plc, Becton, Dickinson and Company, Myriad Genetics Inc., Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lucence Diagnostics Pte. Ltd., GRAIL, Inc., Guardant Health Inc., Exact Sciences Corporation, Freenome Holdings, Inc., among others. Other strategies include forming partnerships among the market players and the research institutions, and technological advanced products and services launches in the forecast period.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7399
Customers can also request for 10% free customization on this report.
“Image guided biopsies, and related technological advancements are in trend in the market. Through a recent study, multi-parametric MRI was confirmed to minimize the false-negative results thereby enhancing the risk assessment. North American region is anticipated to hold the largest market share owing to the excellent healthcare industry that is well established along with the United States Food and Drug Administration approved procedures that increased value for the Clinical Laboratory Improvement Amendment (CLIA)‐developed tests,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Cancer Biopsy Market By Product (Instruments, Kits and Consumables, Services), By Type of Biopsy (Tissue Biopsies (Needle and Surgical Biopsies), Liquid Biopsies, Others), By Application (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, Pancreatic Cancer, Ovarian Cancer, Others), By End User (Reference Laboratories, Hospitals and Physician Laboratories, Academic and Research Centers), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of global cancer biopsy market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in global cancer biopsy.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com/